Clinical Outcomes Study of the Nexel Total Elbow



Status:Recruiting
Conditions:Arthritis, Osteoarthritis (OA), Orthopedic, Orthopedic
Therapuetic Areas:Rheumatology, Orthopedics / Podiatry
Healthy:No
Age Range:18 - Any
Updated:2/8/2019
Start Date:June 2015
End Date:December 2028
Contact:Madison Thompson
Email:madison.thompson@zimmerbiomet.com
Phone:574-373-2265

Use our guide to learn which trials are right for you!

Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow

The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total
Elbow when used in primary or revision total elbow replacement.

The objectives of the study are to confirm safety and performance of the Zimmer® Nexel™ Total
Elbow when used in primary or revision total elbow replacement by analysis of standard
scoring systems, radiographs, and adverse event records.

The safety of the device will be monitored using the frequency and incidence of reporting
adverse events.

The performance of the device will be evaluated by assessing the pain and functional
performance, survival of the device, patient health status, and radiographic success of the
implant.

Inclusion Criteria:

- Patient is 18 years of age or older.

- Patient must have signed Institutional Review Board (IRB)/Ethics Committee
(EC)-approved informed consent.

- Patient is a candidate for primary or revision total elbow arthroplasty, based on
symptoms including at least one of the following:

- Elbow joint destruction which significantly compromises daily living activities

- Post-traumatic lesions or bone loss contributing to elbow instability

- Ankylosed joints, especially cases of bilateral ankylosis from causes other than
active sepsis

- Advanced rheumatoid arthritis, post-traumatic, or degenerative arthritis with
incapacitating pain

- Instability or loss of motion when the degree of joint or soft tissue damage
precludes reliable osteosynthesis

- Acute comminuted articular fracture of elbow joint surfaces that precludes less
radical procedures, including 13-C3 fractures of the distal humerus

- Patient is willing and able to complete scheduled follow-up evaluations as defined by
the protocol.

Additional Retrospective Arm Inclusion Criteria

- Patient must have undergone a total elbow replacement with the Nexel system between
July 2013 and the date of the site initiation visit.

- Patient information available for each retrospective patient must, at minimum, include
preoperative demographic information, preoperative physical exam information, the
index surgery operative report, and details of the devices implanted.

Exclusion Criteria:

- Patient has a currently active or history of repeated local infection at the surgical
site.

- Patient has a current major infection distant from the operative site.

- Patient has a history of prior sepsis.

- Patient suffers from paralysis or dysfunctional neuropathy at the elbow joint.

- Patient has significant ipsilateral hand dysfunction.

- Patient has excessive scarring near the surgical site, which could prevent adequate
soft tissue coverage.

- Patient participates in daily activities that may cause significant stress to an
implanted device such as heavy labor, torsional stress, and/or competitive sports.

- Patient is a prisoner.

- Patient is mentally incompetent or unable to understand what participation in the
study entails.

- Patient is a known alcohol or drug abuser.

- Patient is anticipated to be non-compliant.

- Patient is known to be pregnant.
We found this trial at
4
sites
Charlotte, North Carolina 28207
Principal Investigator: Nady Hamid, MD
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Germantown, Tennessee 38138
Principal Investigator: Thomas W Throckmorton, MD
?
mi
from
Germantown, TN
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
Principal Investigator: Surena Namdari, MD
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
6 Biokatu
Tampere, 33520
Principal Investigator: Pirjo Honkanen, MD
?
mi
from
Tampere,
Click here to add this to my saved trials